National Institute of Health Sponsored Study Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
What does Green Tea do?The possibility of health benefits for green tea has been tossed around the halls of research like a medical football. Some studies says yes some say no and at least one claims that it may even interfere with a cancer drug! A clinical trial has been going on at the University of Arizona to determine what if any value green tea extract may have against cancer. Clinical Trial NIH number NCT00303823 is a randomized phase II trial studying green tea extract to see how well it works (if at all) compared to a placebo in preventing cervical cancer in patients with human papillomavirus and low-grade cervical intraepithelial neoplasia. The cervix is the lower, narrow portion of the uterus (the womb) where it joins with the top end of the vagina.
This is a randomized, double-blind, placebo-controlled study. Patients are randomized to 1 of 2 treatment arms.
A total of 176 patients will be accrued for this study.
"The anticancer potency of green tea and its individual components is being intensely investigated, and some cancer patients already self-medicate with this "miracle herb" in hopes of augmenting the anticancer outcome of their chemotherapy. Bortezomib (BZM) is a proteasome inhibitor in clinical use for multiple myeloma".